TechBio Talks
Podcast Description
Exploring the bold ideas, breakthrough technologies, and visionary people reshaping the future of AI and medicine.
Podcast Insights
Content Themes
The show delves into groundbreaking topics in AI and medicine, highlighting episodes like 'AI in Drug Discovery' and 'The Future of Genomic Medicine,' while focusing on real-world applications and ethical considerations in the TechBio space.
Exploring the bold ideas, breakthrough technologies, and visionary people reshaping the future of AI and medicine.
The third episode of TechBio Talks features host Chris Gibson in conversation with leading AI investor Nathan Benaich of Air Street Capital. Learn about the evolving landscape of AI in drug discovery, the biggest trends identified in Nathan’s new State of AI Report, and what AI investors are looking for, now and in the future.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.